Published guidance, NICE advice and quality standards | Guidance

Showing 551 to 560 of 875

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs	TA537	8 August 2018	8 August 2018
Dupilumab for treating moderate to severe atopic dermatitis	TA534	1 August 2018	1 August 2018
Ocrelizumab for treating relapsing–remitting multiple sclerosis	TA533	25 July 2018	25 July 2018
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer	TA531	18 July 2018	18 July 2018
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy	TA530	4 July 2018	4 July 2018
Beta interferons and glatiramer acetate for treating multiple sclerosis	TA527	27 June 2018	27 June 2018
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	TA217	23 March 2011	20 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia	TA526	13 June 2018	13 June 2018
Guselkumab for treating moderate to severe plaque psoriasis	TA521	13 June 2018	13 June 2018
Midostaurin for untreated acute myeloid leukaemia	TA523	13 June 2018	13 June 2018